Houston, TX, United States of America

Nanospectra Biosciences, Inc.


USPTO Granted Patents = 6


Trademarks = 2

Forward Citations = 78

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Jon Alexander Schwartz (5 out of 9 patents)

silverMedal Glenn Patrick Goodrich (3 out of 3 patents)

bronzeMedal Andrew Mark Murphy (3 out of 3 patents)

4.  J Donald Payne (2 out of 2 patents)

5.  Sunil Krishnan (1 out of 6 patents)

6.  Parmeswaran Diagaradjane (1 out of 1 patent)

7.  James Chunjay Wang (1 out of 1 patent)

8.  Martin Korbling (1 out of 1 patent)

9.  Christopher L Coleman (1 out of 1 patent)

10.  Joseph B Jackson (1 out of 2 patents)

11.  Jon Alexander Schwatrz (0 patent)


6 patents:

Company Overview
Nanospectra Biosciences, Inc. is a biomedical company focused on developing a revolutionary cancer therapy using nanoparticle technology. Their innovative approach utilizes gold nanoparticles to target and destroy cancer cells with minimal impact on healthy tissue. With a commitment to advancing healthcare through cutting-edge research, Nanospectra Biosciences is at the forefront of personalized medicine and oncology treatments.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#726 in Houston, TX

#2,905 in Texas

#44,981 in US

Houston, TX (US)
Houston, TX, United States of America
Forward Citations = 78

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanospectra Biosciences, Inc.. Retrieved from https://idiyas.com/company/nanospectra-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…